For obvious reasons, we are, very sadly, part of an ever-changing community. See our post to find out more about our aims, who we work with, what we've done together & what we're doing to help accelerate progress in @mndresearch@UKMNDRI#United2EndMND
https://t.co/7JPmEcOoIZ
The UK MND Research Institute was the result of #United2EndMND funding campaign in 2021. Bringing together leading research centres from all over UK to implement National Strategy for translational MND research along with vital infrastructure (1/3)
https://t.co/oBra82SpTY
You can read all about the campaign and the unique coalition of patients, researchers, major charities, industry and government on the #United2EndMND website
https://t.co/B39fvEPjZX (2/3)
Traditional clinical trials are essential, but for people with #MND, years of waiting isn't an option.
@EXPERTS_ALS uses short-term biomarker studies to identify promising treatments faster. Take a look at the first wave of drugs entering the platform.
https://t.co/YkAgAjQw4Q
@UKMNDRI's early achievements e.g globally recognised @EXPERTS_ALS drug screening platform, @MNDRegister, bio-banking & fostering a collaborative UK @mndresearch environment have laid strong foundations. Now, sustained, disciplined improvement is vital https://t.co/JgFq24aBjK
Are you an early‑career MND researcher?
Applications are now open for our annual MND EnCouRage event — apply by 30 March for the chance to share your work with the MND community, fellow researchers and leading professionals.
📍 Loughborough
📆 14-15 July
It’s now been 6 long weeks since @blandy_r Dr Rachel Jakeman handed in her open letter to @Keir_Starmer@wesstreeting about the inequity of tofersen access for SOD1 #mnd#als. What’s happening?
https://t.co/CmCwUW8ZYh
Much needed global initiative. Thank you @alscanada. Weak drug candidates/repeated failure have marked #als#mnd research for more than a decade.
Scientific scrutiny MUST be the priority in our disease.
Any #als researcher, esp early career scientists, would benefit from event.
New research reveals what people with #MND/#ALS need when deciding on genetic testing: clear info, implications for family & tailored support.📃
This data can help inform decision aids to assist people when thinking about genetic testing.
Read more🔗
https://t.co/uz8ROz4qDV
My latest ‘Devil is in the detail’ post on the interpretation of #als#mnd trial statistics and other challenges. This one was prompted by the recent criticism of a paper led by Sheffield University published in late 2024.
https://t.co/jtj7n18R26
We've hit 100 sign-ups to our Remote Research Platform!
Thank you to everyone who has signed up; together, we’re building a more inclusive #MND/#ALS research community.
🔗If you haven't joined, sign up below!
https://t.co/TEatvivKnK
Huge thanks to senior UK neurologists who signed this @MNDpatients appreciate your support. We need to avoid respiratory infection so, if having trouble accessing Covid booster, your advice will be a big help https://t.co/s2BM1Fp3JW @mndcampaigns@AmmarAlChalabi@profcjmcdermott
There is also, importantly, a survey on the tools. If you do review the decision aids please complete the survey as the developers want to improve the tools as they go forward.
https://t.co/S943fPQ0H6
#MND#ALS genetic testing is a complex subject both technically & perhaps more importantly whether to have testing if diagnosed or have a family history.
What are implications for you/your family?
New tools from Sheffield & Leeds Unis might help? (1/2)
https://t.co/WFIP4QWKiN
The "clinically extremely vulnerable" with #MND & other serious conditions no longer qualify automatically for Covid booster. Totally illogical when we do qualify for flu vaccine! Pls sign petition https://t.co/uo1FUmB7om @cv_cev@IanByrneMP@AphraBrandreth@_Chris_Coghlan 1/2
Please sign/share this petition. Let’s get 10000 to force government response.
Patients with #mnd#als will die this winter if respiratory compromised if they don’t get the option to have free vaccination.
We need to get mad & in-compassionate policy reversed.
@wesstreeting